Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0259251
Abstract: Background/Objective AUGUSTUS trial demonstrated that, for patients with atrial fibrillation (AF) having acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI), an antithrombotic regimen with apixaban and P2Y12 resulted in less bleeding, fewer hospitalizations,… read more here.
Keywords: atrial fibrillation; treatment; vka; fibrillation acute ... See more keywords
Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cardiovascular Medicine"
DOI: 10.2459/jcm.0000000000000597
Abstract: Introduction The optimal antithrombotic treatment for patients with atrial fibrillation and acute coronary syndrome (ACS), whether or not treated with revascularization, is a complex and debated issue. Clinical practice guidelines are based on expert opinion… read more here.
Keywords: atrial fibrillation; acute coronary; fibrillation acute; coronary syndrome ... See more keywords
Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes.
Sign Up to like & getrecommendations! Published in 2021 at "Reviews in cardiovascular medicine"
DOI: 10.31083/j.rcm2203076
Abstract: If atrial fibrillation (AF) and acute coronary syndrome (ACS) coexist, they should be treated with combined antithrombotic therapy. To reduce the risk of bleeding while maintaining the desired antithrombotic effect, choices should be made for… read more here.
Keywords: atrial fibrillation; fibrillation acute; acute coronary; therapy ... See more keywords